Dipexium Pharmaceuticals Company Profile (NASDAQ:DPRX)

About Dipexium Pharmaceuticals

Dipexium Pharmaceuticals logoDipexium Pharmaceuticals, Inc. is a late-stage pharmaceutical company. The Company is focused on the development and commercialization of Locilex (pexiganan cream 0.8%), a first-in-class, broad spectrum, topical antibiotic. Locilex is focused on the treatment of mild infections of diabetic foot ulcers (Mild DFI). As a topical antibiotic, Locilex affects only the area to which it is applied, and does not spread to the entire body through the bloodstream, which is host to a number of different bacteria other than bacteria causing the skin infection. It is conducting over two Phase III clinical trials of Locilex for the treatment of Mild DFI (DPX-305 and DPX-306) in the United States. The Company has conducted over two separate Phase I skin irritation and skin sensitization studies. Locilex has demonstrated statistical non-inferiority to a systemic antibiotic in a randomized, active-controlled double blind, multi-center clinical study in patients with Mild or Moderate DFI.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: DPRX
  • CUSIP:
Key Metrics:
  • Previous Close: $15.53
  • 50 Day Moving Average: $13.03
  • 200 Day Moving Average: $10.91
  • 52-Week Range: $6.04 - $16.32
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -8.49
  • P/E Growth: -0.18
  • Market Cap: $161.48M
  • Outstanding Shares: 10,398,000
  • Beta: 1.77
Profitability:
  • Return on Equity: -75.82%
  • Return on Assets: -73.13%
Debt:
  • Current Ratio: 24.22%
  • Quick Ratio: 24.22%
Additional Links:
Companies Related to Dipexium Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Dipexium Pharmaceuticals (NASDAQ:DPRX) (?)
Ratings Breakdown: 1 Strong Buy Rating
Consensus Rating:Strong Buy (Score: 4.00)
Consensus Price Target: $22.00 (41.66% upside)

Analysts' Ratings History for Dipexium Pharmaceuticals (NASDAQ:DPRX)
Show:
DateFirmActionRatingPrice TargetDetails
3/25/2016Raymond James Financial Inc.Lower Price TargetStrong-Buy$22.00View Rating Details
(Data available from 9/25/2014 forward)

Earnings

Earnings History for Dipexium Pharmaceuticals (NASDAQ:DPRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/14/2016        
8/4/2016Q216($0.54)($0.52)ViewN/AView Earnings Details
5/12/2016Q116($0.52)($0.56)ViewListenView Earnings Details
11/16/2015Q315($0.47)($0.49)ViewListenView Earnings Details
8/13/2015Q215($0.43)($0.47)ViewListenView Earnings Details
5/14/2015Q115($0.44)($0.49)ViewListenView Earnings Details
4/14/2015($0.44)($0.38)ViewN/AView Earnings Details
3/24/2015Q414$0.52($0.38)ViewN/AView Earnings Details
11/13/2014($0.49)($0.45)ViewN/AView Earnings Details
8/12/2014($0.37)($0.46)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Dipexium Pharmaceuticals (NASDAQ:DPRX)
Current Year EPS Consensus Estimate: $-2.1 EPS
Next Year EPS Consensus Estimate: $-1.83 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.51)($0.51)($0.51)
Q3 20161($0.41)($0.41)($0.41)
Q4 20161($0.35)($0.35)($0.35)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Dipexium Pharmaceuticals (NASDAQ:DPRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Dipexium Pharmaceuticals (NASDAQ:DPRX)
Insider Ownership Percentage: 47.70%
Institutional Ownership Percentage: 24.78%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/21/2014Jack H DeanDirectorBuy3,000$9.00$27,000.00View SEC Filing  
3/18/2014David GarrettVPBuy2,083$12.00$24,996.00View SEC Filing  
3/18/2014Thomas L HarrisonDirectorBuy2,000$12.00$24,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Dipexium Pharmaceuticals (NASDAQ:DPRX)
DateHeadline
capitalcube.com logoDipexium Pharmaceuticals, Inc. :DPRX-US: Earnings Analysis: Q2, 2016 By the Numbers : September 16, 2016 (NASDAQ:DPRX)
www.capitalcube.com - September 16 at 4:34 PM
capitalcube.com logoDipexium Pharmaceuticals, Inc. :DPRX-US: Earnings Analysis: Q2, 2016 By the Numbers : September 16, 2016 (NASDAQ:DPRX)
www.capitalcube.com - September 16 at 4:34 PM
publicnow.com logoDipexium Pharmaceuticals Announces Issuance of Locilex® Patent by European Union (NASDAQ:DPRX)
www.publicnow.com - September 7 at 4:48 PM
publicnow.com logoDipexium Pharmaceuticals Announces Participation in September Investor Conferences (NASDAQ:DPRX)
www.publicnow.com - August 24 at 4:37 PM
sg.finance.yahoo.com logoDipexium Pharmaceuticals posts 2Q loss (NASDAQ:DPRX)
sg.finance.yahoo.com - August 4 at 8:53 AM
biz.yahoo.com logoQ2 2016 Dipexium Pharmaceuticals Inc Earnings Release - Before Market Open (NASDAQ:DPRX)
biz.yahoo.com - August 4 at 8:53 AM
publicnow.com logoDipexium Pharmaceuticals Reports Second Quarter 2016 Financial Results (NASDAQ:DPRX)
www.publicnow.com - August 4 at 8:53 AM
finance.yahoo.com logoDipexium Pharmaceuticals to Hold Second Quarter 2016 Financial Results Conference Call on Thursday, August … (NASDAQ:DPRX)
finance.yahoo.com - July 28 at 3:22 PM
publicnow.com logoDipexium Pharmaceuticals to Hold Second Quarter 2016 Financial Results Conference Call on Thursday, August 4, 2016, at 8:30 a.m. ET (NASDAQ:DPRX)
www.publicnow.com - July 28 at 7:18 AM
publicnow.com logoDipexium Pharmaceuticals' Locilex® Microbiology Data Presented at ASM Microbe 2016 Conference (NASDAQ:DPRX)
www.publicnow.com - June 20 at 4:09 PM
capitalcube.com logoDipexium Pharmaceuticals, Inc. :DPRX-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016 (NASDAQ:DPRX)
www.capitalcube.com - June 6 at 2:33 PM
biz.yahoo.com logoDIPEXIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:DPRX)
biz.yahoo.com - May 26 at 9:28 AM
publicnow.com logoDipexium Announces Completion of Enrollment Objective in OneStep-1 Pivotal Phase 3 Clinical Trial (NASDAQ:DPRX)
www.publicnow.com - May 16 at 8:32 AM
rttnews.com logoADRO Earns Milestone Payment, Hope & Allstar Await CAPR, CATB Ahead Of Time (NASDAQ:DPRX)
www.rttnews.com - May 13 at 6:57 AM
biz.yahoo.com logoQ1 2016 Dipexium Pharmaceuticals Inc Earnings Release - Before Market Open (NASDAQ:DPRX)
biz.yahoo.com - May 12 at 7:07 AM
finance.yahoo.com logoDipexium Pharmaceuticals Announces Completion of Enrollment Objective in OneStep-2 Pivotal Phase 3 Clinical Trial and First Quarter 2016 Financial Results (NASDAQ:DPRX)
finance.yahoo.com - May 12 at 7:00 AM
publicnow.com logoDipexium Pharmaceuticals to Hold First Quarter 2016 Financial Results Conference Call on Thursday, May 12, 2016, at 8:30 a.m. ET (NASDAQ:DPRX)
www.publicnow.com - May 9 at 8:18 AM
finance.yahoo.com logoDipexium Pharmaceuticals (DPRX) Jumps: Stock Rises 7.5% (NASDAQ:DPRX)
finance.yahoo.com - April 29 at 8:40 AM
forbes.com logoIs Allergan On The Prowl For New Deals? (NASDAQ:DPRX)
www.forbes.com - April 27 at 4:24 PM
finance.yahoo.com logoWill Dipexium Pharmaceuticals (DPRX) Continue to Surge Higher? (NASDAQ:DPRX)
finance.yahoo.com - April 27 at 8:03 AM
News IconDipexium Pharmaceuticals Incorporated (NASDAQ:DPRX) Short Interest Increased By 10.68% (NASDAQ:DPRX)
www.bibeypost.com - April 21 at 7:14 AM
finance.yahoo.com logoWhy You Shouldn't Bet Against Dipexium Pharmaceuticals (DPRX) Stock (NASDAQ:DPRX)
finance.yahoo.com - April 8 at 8:52 AM
publicnow.com logoDipexium Pharmaceuticals Announces Issuance of Locilex® Patent in Japan (NASDAQ:DPRX)
www.publicnow.com - March 28 at 8:21 AM
finance.yahoo.com logo8:04 am Dipexium Pharmaceuticals announces issuance of Locilex patent in Japan (NASDAQ:DPRX)
finance.yahoo.com - March 28 at 8:04 AM
publicnow.com logoDipexium Pharmaceuticals Reports 2015 Financial Results (NASDAQ:DPRX)
www.publicnow.com - March 23 at 7:09 AM
biz.yahoo.com logoQ4 2015 Dipexium Pharmaceuticals Inc Earnings Release - Before Market Open (NASDAQ:DPRX)
biz.yahoo.com - March 23 at 7:07 AM
biz.yahoo.com logoDIPEXIUM PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report (NASDAQ:DPRX)
biz.yahoo.com - March 22 at 12:00 PM
thestreet.com logoImplied IWC Analyst Target Price: $86 (NASDAQ:DPRX)
www.thestreet.com - March 18 at 11:28 AM
finance.yahoo.com logoDipexium Pharmaceuticals to Hold Year End 2015 Financial Results Conference Call on Wednesday, March 23, 2016, 8:30 a.m. ET (NASDAQ:DPRX)
finance.yahoo.com - March 14 at 7:00 AM
finance.yahoo.com logoDipexium Pharmaceuticals Announces Presentation at Raymond James 37th Annual Institutional Investors Conference (NASDAQ:DPRX)
finance.yahoo.com - March 2 at 8:00 AM
biz.yahoo.com logoDIPEXIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements a (NASDAQ:DPRX)
biz.yahoo.com - February 17 at 4:30 PM
finance.yahoo.com logoDipexium Pharmaceuticals Reaches 75% Enrollment Milestone in Pivotal Phase 3 Clinical Trials (NASDAQ:DPRX)
finance.yahoo.com - February 4 at 8:00 AM
publicnow.com logoDipexium Pharmaceuticals Announces Issuance of Locilex® Patents in Australia and New Zealand (NASDAQ:DPRX)
www.publicnow.com - February 1 at 8:20 AM
publicnow.com logoDipexium Pharmaceuticals Announces Presentation at 18th Annual BIO CEO & Investor Conference (NASDAQ:DPRX)
www.publicnow.com - January 29 at 8:21 AM
finance.yahoo.com logoDipexium Pharmaceuticals, Inc. (DPRX) (NASDAQ:DPRX)
finance.yahoo.com - January 27 at 10:15 AM
biz.yahoo.com logoDIPEXIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:DPRX)
biz.yahoo.com - January 11 at 2:30 PM
noodls.com logoDipexium Pharmaceuticals Announces Presentation at Biotech Showcase™ 2016 (NASDAQ:DPRX)
www.noodls.com - January 6 at 7:21 AM
insidermonkey.com logoIs Dipexium Pharmaceuticals Inc (DPRX) A Good Stock To Buy? (NASDAQ:DPRX)
www.insidermonkey.com - December 11 at 4:29 AM
finance.yahoo.com logoDIPEXIUM PHARMACEUTICALS, INC. Financials (NASDAQ:DPRX)
finance.yahoo.com - December 8 at 1:18 PM
noodls.com logoDipexium Pharmaceuticals Announces Presentation at Oppenheimer 26th Annual Healthcare Conference (NASDAQ:DPRX)
www.noodls.com - December 1 at 8:13 AM
biz.yahoo.com logoDIPEXIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement (NASDAQ:DPRX)
biz.yahoo.com - November 16 at 9:02 AM
noodls.com logoDipexium Pharmaceuticals Reports Third Quarter 2015 Financial Results (NASDAQ:DPRX)
www.noodls.com - November 16 at 7:14 AM
biz.yahoo.com logoQ3 2015 Dipexium Pharmaceuticals Inc Earnings Release - 07:00 am ET (NASDAQ:DPRX)
biz.yahoo.com - November 16 at 7:07 AM
biz.yahoo.com logoDIPEXIUM PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:DPRX)
biz.yahoo.com - November 13 at 4:23 PM
noodls.com logoDipexium Pharmaceuticals to Hold Third Quarter 2015 Financial Results Conference Call on Monday, November 16, 2015, at 8:30 a.m. ET (NASDAQ:DPRX)
www.noodls.com - November 9 at 8:16 AM

Social

Dipexium Pharmaceuticals (NASDAQ:DPRX) Chart for Sunday, September, 25, 2016


Last Updated on 9/25/2016 by MarketBeat.com Staff